Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
52.24
+0.71 (1.37%)
Nov 21, 2024, 2:39 PM EST - Market open

Viking Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-99.15-85.9-68.87-54.99-39.5-25.78
Upgrade
Depreciation & Amortization
0.310.290.290.30.280.26
Upgrade
Other Amortization
0.10.090.060.020.110.29
Upgrade
Loss (Gain) From Sale of Investments
-16.05-8.21.223.913.770.47
Upgrade
Stock-Based Compensation
28.1316.758.676.15.823.74
Upgrade
Other Operating Activities
0.040.040.040.010.030.05
Upgrade
Change in Accounts Payable
-5.46-1.027.09-2.541.561.47
Upgrade
Change in Other Net Operating Assets
17.844.573.1-0.386.16-5.26
Upgrade
Operating Cash Flow
-74.25-73.38-48.4-47.59-21.78-24.75
Upgrade
Investment in Securities
-524.22-179.0954.7537.9641.577.46
Upgrade
Investing Cash Flow
-524.22-179.0954.7537.9641.577.46
Upgrade
Issuance of Common Stock
653.75278.512.517.631.271.11
Upgrade
Repurchase of Common Stock
-42.1-7.12-8.33-0.71-0.3-0.15
Upgrade
Other Financing Activities
---0.02-0.05-0.03-0.07
Upgrade
Financing Cash Flow
611.65271.384.166.880.950.89
Upgrade
Foreign Exchange Rate Adjustments
-0.02-0.03-0.26---
Upgrade
Net Cash Flow
13.1618.8810.26-2.7520.74-16.4
Upgrade
Free Cash Flow
-74.25-73.38-48.4-47.59-21.78-24.75
Upgrade
Free Cash Flow Per Share
-0.70-0.78-0.63-0.62-0.30-0.34
Upgrade
Levered Free Cash Flow
-44.29-42.36-25.22-32.16-15.06-21.56
Upgrade
Unlevered Free Cash Flow
-44.33-42.4-25.24-32.16-15.1-21.61
Upgrade
Change in Net Working Capital
-10.97-3.58-9.763.76-5.475.33
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.